What's in it for you?
Being part of BioVentureHub, located within AstraZeneca’s R&D center in Gothenburg, is special.
Here, emerging companies and academic groups, within life science, are given the opportunity to grow, collaborate, and exchange knowledge in close connection with AstraZeneca scientific expertise, and with access to world-class facilities, networks and ecosystem.
It's not just a physical space; it's a community where knowledge is the currency and sharing is the culture.
As a member of the community, companies and organisations gain access to community support, partnership programs, networks and alumni companies within GoCo Health Innovation City, the dynamic Gothenburg Life Science Cluster, and broader ecosystems connected to AstraZeneca as a global company.
We are not only turning challenges into opportunities.
We are Growing Innovation Together!
What we offer!
Inside AstraZenecas vibrant R&D site in Gothenburg, where BioVentureHub is located, it is all about providing acess to scientific expertise, world-class infrastructure, and a thriving communtiy in an ecosystem designed for collaboration. BioVentureHub offers unique industrial support.
- Integrated at AstraZeneca’s strategic R&D site in Gothenburg
- Facility services
- Environmental permit
- Access to broad range of AstraZeneca expertise
- Access to digital and analogue infrastracture
- Tailor-made support – large pharma input & perspective
- Knowledge-sharing
- De-risking of technology
- Quid Pro Quo, e.g. access to data, samples
- Seminar & networking events
- Partnership programs
- Sustainability initiatives
- Broader ecosystems, like -
GoCo Health Innovation City
Focus Areas - Challenges we can solve together
We are looking for new companies within the following areas.
Pharma
New modalities and drug delivering technologies
- Targeted delivery (beyond the liver)
- Novel drug delivery systems
- Oligonucleotides (solid phase or enzymatic synthesis) and automated design (ML/AI) & synthesis
Digital/Data/AI
AI/ML for faster development of safer and better drugs
- Predictive modelling
- Cutting-edge technologies for target identification/validation
- Digital diagnostics
- AI-powered tools for clinical/regulatory automation
Deep tech
Pharma R&D enabling technologies
- Advanced cell systems, including 3D organoid models
- Safety omics & cell painting
- Diagnostic reagent development
SustainTech
Biocatalysis
- Enzyme engineering
- Scale-up and green manufacturing
- Environmental/waste treatment
Green chemistry
- Sustainability by design
- Predictive environmental toxicology
- Life cycle analysis (LCA)
- Waste reduction / Circular production
Impact stories
In an effort to provide you with a window into the BioVentureHub community, we seek to outline the inherent value of participating in this thriving ecosystem. Through these impact stories, we offer a glimpse into the unique benefits of engaging with our community, including access to AstraZeneca's Infrastructure, Expertise, Collaborative ethos, Dare to Share Culture and work with our AstraZeneca approach on Sustainabiltiy.. By exploring these narratives, you will gain an understanding of how the BioVentureHub fosters the growth of emerging life science companies, drives pioneering advancements, and nurtures an environment of collaborative innovation.
Leveraging AstraZeneca infrastructure and expertise
A testament to the success of the BioVentureHub is evident in the growth stories of three of our alumni companies based at GoCo Health Innovation City.
OnDosis, Promimic, and I-Tech leveraged the resources and expertise available at the BioVentureHub to accelerate their development, secure investments and reach significant business milestones.
Read more about their impactful growth journeys.
How the BioVentureHub facilitates collaboration with AstraZeneca
AstraZeneca BioVentureHub has enabled over 90 legal agreements between AstraZeneca and SMEs/enterprises/academic groups, harnessing their agility, specialized expertise, and innovative capabilities. This model allows strategically relevant SMEs and academic groups to gain from AstraZeneca’s knowledge & infrastructure, to get tailored product development opportunities and global reach, enabling them to scale innovations and bring products to market more efficiently.
Cultivating a “dare to share” culture for life science innovation
Sweden’s position as a global innovation leader is deeply rooted in its unique culture of collaboration and resourcefulness.
Since BioVentureHub established 2014, we have created a lot of value, together with our member companies, collaborative AstraZeneca scientists and ecosystem partners. There are many things that sets us apart from our colleagues in the innovation industry. One thing specifically is the unique dare to share culture based on experimental, explorative and sometimes trial and error approach and experience. It takes years of curiosity in order to create the future together.
AstraZeneca’s sustainability approach to emerging companies
AstraZeneca’s BioVentureHub is more than an innovation hub—it’s a sustainability accelerator for life science and sustainability tech innovators. With a sharper focus on attracting sustainability tech companies and research, the BioVentureHub offers a unique environment where companies can co-locate, scale and innovate while integrating sustainable business practices.
